Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Sales, net	$ 50,672	$ 56,246
Cost of sales	46,611	49,694
Gross profit	4,061	6,552
Selling and administrative expenses	3,941	3,807
Operating income	120	2,745
Other income (expense), net:
Interest expense	(52)	(128)
Unrealized gain (loss) on investment in iBio Stock	27	(55)
Realized loss on sale of investment in iBio Stock	(35)	0
Other income	40	35
Total other income (expense), net	(20)	(148)
Income before income taxes	100	2,597
Income tax (expense) benefit, net	(134)	1,241
Net (loss) income	$ (34)	$ 3,838
Basic net (loss) income per common share (in dollars per share)	$ (0.00)	$ 0.13
Diluted net (loss) income per common share (in dollars per share)	$ (0.00)	$ 0.12
Weighted average common shares outstanding - basic (in shares)	29,949,610	29,843,386
Add: Equivalent shares outstanding - stock options (in shares)	0	2,477,939
Weighted average common shares outstanding - diluted (in shares)	29,949,610	32,321,326